Empirical Finance’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$606K Sell
2,416
-3
-0.1% -$746 0.03% 386
2025
Q4
$666K Sell
2,419
-102
-4% -$27.9K 0.03% 364
2025
Q3
$661K Buy
2,521
+24
+1% +$5.83K 0.03% 386
2025
Q2
$546K Buy
2,497
+21
+0.8% +$4.49K 0.03% 410
2025
Q1
$554K Buy
2,476
+80
+3% +$22K 0.03% 389
2024
Q4
$785K Sell
2,396
-20
-0.8% -$6.29K 0.05% 317
2024
Q3
$725K Buy
2,416
+57
+2% +$17.5K 0.04% 339
2024
Q2
$777K Sell
2,359
-147
-6% -$52K 0.05% 313
2024
Q1
$992K Buy
2,506
+89
+4% +$32.9K 0.06% 277
2023
Q4
$851K Buy
2,417
+23
+1% +$8.14K 0.06% 288
2023
Q3
$898K Buy
2,394
+236
+11% +$91.3K 0.07% 257
2023
Q2
$825K Buy
2,158
+279
+15% +$99.7K 0.06% 270
2023
Q1
$651K Buy
1,879
+85
+5% +$24.8K 0.06% 297
2022
Q4
$422K Buy
1,794
+157
+10% +$37.2K 0.04% 370
2022
Q3
$403K Buy
1,637
+298
+22% +$90.8K 0.05% 332
2022
Q2
$405K Buy
1,339
+75
+6% +$24.4K 0.05% 323
2022
Q1
$519K Buy
1,264
+153
+14% +$59.9K 0.06% 300
2021
Q4
$521K Buy
1,111
+358
+48% +$154K 0.06% 287
2021
Q3
$320K Buy
753
+59
+9% +$24.9K 0.05% 335
2021
Q2
$249K Buy
+694
New +$229K 0.04% 362

Other funds holding WST